学校と認知心理学の国際ジャーナル
オープンアクセス

概要

バイオマーカーと臨床試験設計の関連性

ギャビン・コニー

Precision medicine has proven to achieve success in treating cancers because it is ready-made to a patient’s specific needs. due to this tradition approach to treatment, however, planning a clinical test for precision medicine is markedly tougher than more conventional treatments. Unlike traditional drugs and biologics, clinical test designs for precision medicine must consider patients’ variability in genes. As a result, biomarker use in precision medicine has been critical for outlining patient segments, selecting trial locations and measuring trial success